ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2025
Atypical teratoid rhabdoid tumor with extraneural metastases: a case report with genomic analysis.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atypical teratoid/rhabdoid tumor (ATRT) is an aggressive malignancy localized to the neuroaxis. It predominantly affects infants and young children, with exceedingly rare occurrences in adolescents and young adults. While its central nervous system (CNS) dissemination is common, extraneural metastases are exceptionally rare. We present a case of brain ATRT in a 16-year-old patient who, 8 months after the initial remission, developed an extraneural relapse involving visceral and skeletal sites. This unusual presentation posed significant diagnostic challenges in differentiating relapse from a second primary rhabdoid neoplasm. Comparative genomic analysis using a multigene panel found identical mutations in both the primary CNS tumor and a relapsed lesion, confirming their common clonal origin and ruling out a second de novo malignancy. Our case underscores the importance of awareness about the possibility of systemic relapse of ATRT. To our knowledge, this is the first report of applying comparative genomic profiling to discriminate between metastatic relapse and a second primary. Larger studies are needed to validate this approach in diverse tumor types.
Indexed as
Identifiers
41379345What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.